Journal Summary - Discover more summaries and articles from M3 India

Journal Summaries

General Medicine

Clinical Pharmacology

Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma

Cancer | Jan 03, 2018 Clinical Pharmacology

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin

Journal of Neurology | Jan 03, 2018 Clinical Pharmacology

Rituximab maintenance vs observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): An open-label, randomised phase 3 study

The Lancet Haematology | Jan 02, 2018 Clinical Pharmacology

Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis

Alimentary Pharmacology and Therapeutics | Jan 01, 2018 Clinical Pharmacology

Ethnic differences in efficacy and safety of alogliptin: A systematic review and meta-analysis

Diabetes Therapy | Evidence based | Jan 01, 2018 Clinical Pharmacology

Momelotinib vs best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): A randomised, open-label, phase 3 trial

The Lancet Haematology | Jan 01, 2018 Clinical Pharmacology

A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)

Journal of Neurology, Neurosurgery & Psychiatry | Dec 30, 2017 Clinical Pharmacology

Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia

Schizophrenia Research | Dec 29, 2017 Clinical Pharmacology

Efficacy and safety of once-weekly semaglutide vs exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-week, open-label, randomized clinical trial

Diabetes Care | Dec 28, 2017 Clinical Pharmacology

Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study

Acta Neurologica Scandinavica | Dec 28, 2017 Clinical Pharmacology

« Prev 1 … 264 265 266 267 268 … 338 Next »

Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin

Rituximab maintenance vs observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): An open-label, randomised phase 3 study

Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis

Ethnic differences in efficacy and safety of alogliptin: A systematic review and meta-analysis

Momelotinib vs best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): A randomised, open-label, phase 3 trial

A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)

Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia

Efficacy and safety of once-weekly semaglutide vs exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-week, open-label, randomized clinical trial

Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

The Role of Nutrition in Enhancing Fertility for Men and Women

Effect of Collagen Vascular Diseases on Eyes: MCQ Challenge

More Women Experience Chronic Pain Than Men: Find Out Why

Phase 2 and biomarker study of trebananib, an angiopoietin-blocking peptibody, with and without bevacizumab for patients with recurrent glioblastoma

INTEREST IN CD2, a global patient-centred study of long-term cervical dystonia treatment with botulinum toxin

Rituximab maintenance vs observation following abbreviated induction with chemoimmunotherapy in elderly patients with previously untreated chronic lymphocytic leukaemia (CLL 2007 SA): An open-label, randomised phase 3 study

Safety and efficacy of sofosbuvir-based treatment of acute hepatitis C in end-stage renal disease patients undergoing haemodialysis

Ethnic differences in efficacy and safety of alogliptin: A systematic review and meta-analysis

Momelotinib vs best available therapy in patients with myelofibrosis previously treated with ruxolitinib (SIMPLIFY 2): A randomised, open-label, phase 3 trial

A standardised frankincense extract reduces disease activity in relapsing-remitting multiple sclerosis (the SABA phase IIa trial)

Antipsychotics and mortality in a nationwide cohort of 29,823 patients with schizophrenia

Efficacy and safety of once-weekly semaglutide vs exenatide ER in subjects with type 2 diabetes (SUSTAIN 3): A 56-week, open-label, randomized clinical trial

Adjunctive perampanel in partial-onset seizures: Asia-Pacific, randomized phase III study

Alternative Therapies and Infection Management

'Weekend Warrior' Trend: Health Perks for Busy Physicians

The Role of Nutrition in Enhancing Fertility for Men and Women

Effect of Collagen Vascular Diseases on Eyes: MCQ Challenge

More Women Experience Chronic Pain Than Men: Find Out Why

Select Specialty

Select Topic